A 58-year-old man with HFrEF (LVEF 30%) NYHA II is newly diagnosed. Which disease-modifying regimen should be initiated and up-titrated first-line?...

Question

A 58-year-old man with HFrEF (LVEF 30%) NYHA II is newly diagnosed. Which disease-modifying regimen should be initiated and up-titrated first-line?

Accepted Answer

ACE inhibitor plus evidence-based beta-blocker

Answer

Digoxin monotherapy

Answer

Loop diuretic plus nitrate

Answer

Ivabradine plus diuretic

Answer

Hydralazine and isosorbide dinitrate alone

ukmla MCQ (SBA): Heart Failure with reduced EF